ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,391 | -31.5% | 12,000 | 0.0% | 0.00% | – |
Q4 2022 | $2,032 | +1.6% | 12,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | -66.7% | 12,000 | 0.0% | 0.00% | – |
Q2 2022 | $6,000 | -14.3% | 12,000 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | 0.0% | 12,000 | 0.0% | 0.00% | – |
Q4 2021 | $7,000 | -41.7% | 12,000 | 0.0% | 0.00% | – |
Q3 2021 | $12,000 | -7.7% | 12,000 | 0.0% | 0.00% | – |
Q2 2021 | $13,000 | +18.2% | 12,000 | 0.0% | 0.00% | – |
Q1 2021 | $11,000 | +83.3% | 12,000 | 0.0% | 0.00% | – |
Q4 2020 | $6,000 | -33.3% | 12,000 | 0.0% | 0.00% | – |
Q3 2020 | $9,000 | 0.0% | 12,000 | -25.0% | 0.00% | – |
Q2 2020 | $9,000 | +50.0% | 16,000 | 0.0% | 0.00% | – |
Q1 2020 | $6,000 | -45.5% | 16,000 | 0.0% | 0.00% | – |
Q4 2019 | $11,000 | 0.0% | 16,000 | 0.0% | 0.00% | – |
Q3 2019 | $11,000 | -47.6% | 16,000 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $21,000 | -41.7% | 16,000 | -5.9% | 0.00% | 0.0% |
Q1 2019 | $36,000 | -5.3% | 17,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $38,000 | – | 17,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sterling Global Strategies LLC | 21,940 | $71,000 | 0.46% |
Leisure Capital Management | 157,301 | $503,000 | 0.43% |
BARD ASSOCIATES INC | 759,000 | $2,430,000 | 0.23% |
Stonebridge Capital Advisors LLC | 32,500 | $104,000 | 0.02% |
LEVEL FOUR ADVISORY SERVICES, LLC | 63,500 | $203,000 | 0.02% |
DekaBank Deutsche Girozentrale | 700,000 | $2,240,000 | 0.02% |
B. Riley Wealth Advisors, Inc. | 21,350 | $69,000 | 0.01% |
Jacobi Capital Management LLC | 7,421 | $24,000 | 0.01% |
Versant Capital Management, Inc | 4,092 | $13,000 | 0.01% |
Cable Hill Partners, LLC | 4,000 | $13,000 | 0.01% |